islet
Islet HomeAbout Us
The Emory Center for Islet Transplantation, funded through a generous grant from the Juvenile Diabetes Research Foundation, opened in June 2002. Emory's Center is one of only a handful of such Centers in the world, and the only one in Georgia. Islet transplantation in the United States is still being researched, and at Emory University this research is in the form of a clinical trial. The objective of the clinical trial is to determine if the successful islet transplant results observed by other institutions can be reproduced at Emory. We also work to contribute further to advances in the field of islet transplantation. Currently recipients of islet transplant must take immunosuppressive drugs to prevent rejection; therefore islet transplantation is only appropriate for patients with specific problems associated with brittle diabetes.